DALLAS, Sept. 25, 2024 /PRNewswire/ — Loopback Analytics was selected for the Dallas Business Journal’s Fast 50, an annual ranking of the fastest-growing middle market companies in North Texas.
The Dallas Business Journal’s annual Fast 50 program honors the fastest-growing private and public companies based in Dallas-Fort Worth that are nominated based on revenue growth from the last 3 years. Eligible companies have annual revenue between $10 million and $1 billion.
With a growth rate of 205.2%, Loopback’s success landed among the top 10 nominees. “We’re proud to be recognized for our rapid growth, as it reflects our commitment to innovation and excellence,” says Neil Smiley, CEO and Founder of Loopback Analytics.
The 50 companies were honored, and the rankings revealed at an event on September 11th at The Fairmont in Dallas, with digital coverage following the event and a special print edition on September 13th.
Click here for more information on this year’s list: https://www.bizjournals.com/dallas/news/2024/07/17/this-years-fast-50-companies-revealed.html?cx_testId=40&cx_testVariant=cx_7&cx_artPos=2#cxrecs_s
About Loopback Analytics
Founded in 2009, Loopback Analytics is a leading provider of data analytics and insights that simplify understanding, access and innovation for patients requiring specialty care. Our mission is to connect Health Systems and Life Sciences through analytics and data-enabled services.
About the Dallas Business Journal
Founded in 1977, the Dallas Business Journal is the premier source for local business news, research and events in Dallas-Fort Worth. From breaking news to live events, the Business Journal serves its readers by helping them grow their businesses, advance their careers and simplify their professional lives.
SOURCE Loopback Analytics
Compassion Center Austin introduces Texans to natural pain management and opioid risk reduction through the…
WARSAW, POLAND / ACCESSWIRE / September 27, 2024 / Humaneva Inc. has entered into a…
Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic painMIAMI, FL /…
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the…
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the…
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS”…